Related references
Note: Only part of the references are listed.Efficacy of Nintedanib in Idiopathic Pulmonary Fibrosis across Prespecified Subgroups in INPULSIS
Ulrich Costabel et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis
Lutz Wollin et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
The INPULSIS enigma: exacerbations in idiopathic pulmonary fibrosis
Samy Suissa et al.
THORAX (2015)
Effect of baseline FVC on lung function decline with nintedanib in patients with IPF
Toby M. Maher et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Epidemiologic Survey of Japanese Patients with Idiopathic Pulmonary Fibrosis and Investigation of Ethnic Differences
Motoki Natsuizaka et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Design of the INPULSIS™ trials: Two phase 3 trials of nintedanib in patients with idiopathic pulmonary fibrosis
Luca Richeldi et al.
RESPIRATORY MEDICINE (2014)
Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis
Brett Ley et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
Luca Richeldi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
BIBF 1120: Triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy
Frank Hilberg et al.
CANCER RESEARCH (2008)
Idiopathic pulmonary fibrosis
Eric B. Meltzer et al.
ORPHANET JOURNAL OF RARE DISEASES (2008)
Share Paper
